Relievant Medsystems Introduces Next-Gen Access Instruments

The next-generation access instruments support the Intracept procedure for chronic vertebrogenic low back pain.

Relievant Medsystems Announces Favorable Coverage for Intracept Procedure

The coverage by Cigna Healthcare expands access to the procedure, when clinically appropriate, to patients in all 50 states as well as Washington D.C. and Puerto Rico.

Trial Results Validate Intracept for Vertebrogenic Pain

Pooled 3-year outcomes from Intracept procedures demonstrate long-term pain relief and reduced opioid use in chronic vertebrogenic low back pain patients.

10,000 Patients Treated with Intracept for Low Back Pain

Relievant Medsystems announced that more than 10,000 patients have been treated with the Intracept procedure for vertebrogenic low back pain.

New CPT Codes for Relievant Medsystems’ Intracept Procedure

The diagnosis codes pertain to Intracept Intraosseous Nerve Ablation, used in the treatment of chronic low back pain.

Study Results: Relievant Medsystems’ INTRACEPT in Back Pain

Study Results validate the superiority of basivertebral nerve ablation vs. standard of care.

Relievant Medsystems Closes $70 Million Financing to Accelerate U.S. Launch of Intracept Procedure

Intracept is a commercially-available treatment to treat patients suffering from chronic lower back pain from degenerative disk disease.